Home / TUNEL Assays / TumorTACS In Situ Apoptosis Detection Kit

TumorTACS In Situ Apoptosis Detection Kit

Catalog #: 4815-30-K
21 Citations Datasheet / COA / SDS
In situ detection of apoptosis in fixed frozen, paraffin embedded, or plastic embedded cells and tissues
Catalog # Availability Size / Price Qty
4815-30-K
TumorTACS In Situ Apoptosis Detection Kit_Mammary Tumor_4815-30-K
1 Image
Product Details
Citations (21)
FAQs
Reviews
Summary Product Datasheets Data Images

TumorTACS In Situ Apoptosis Detection Kit Summary

A complete TUNEL assay based kit tailored for the detection of DNA fragmentation associated with apoptosis in tumors or cancer cells.
 

Key Benefits

• Unique buffer system produces more consistent labeling.
• Performance tested on tumor samples.
• Includes both Proteinase K and  exclusive non-enzymatic Cytonin permeabilization reagent.
• Includes TACS-Nuclease solution for preparing sample-dependent positive controls.
• Helps resolve unique problems encountered when using tissues or cells from tumors.

Why Use TumorTACS In Situ Apoptosis Detection Kit?

The labeling of tumor-containing specimens can be problematic due to the high levels of necrosis in these tissues. During necrosis, cessation of homeostasis, cell swelling, and nuclear membrane rupture generates highly degraded DNA that can interfere with interpretation of data.

Product Specifications

  • In situ detection of apoptosis in fixed frozen, paraffin embedded, or plastic embedded cells and tissues.
  • Assists in the identification of apoptotic morphologies.

Kit Contents

• Proteinase K
• Streptavidin-HRP
• Diaminobenzidine
• DAB Enhancer
• TACS-Nuclease
• TACS-Nuclease Buffer
• Methyl Green 1%
• TACS 2 TdT Labeling Buffer
• TACS 2 TdT Stop Buffer
• TACS 2 TdT dNTP
• TdT Enzyme
• 50x Manganese Cation
• Cytonin

Specifications

Shipping Conditions
The components for this kit may require different storage/shipping temperatures and may arrive in separate packaging. Upon receipt, store products immediately at the temperature recommended on the product labels.
Storage
Store the unopened product at -20 to -70 °C. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Do not use past expiration date.
Species
N/A

Limitations

For research use only. Not for diagnostic use.

Product Datasheets

You must select a language.

x
Product Datasheet
COA

Scientific Data

N/A TumorTACS In Situ Apoptosis Detection Kit_Mammary Tumor_4815-30-K View Larger

Apoptotic Cells within a Mouse Mammary Tumor Identified using the TumorTACS In Situ Apoptosis Detection Kit. Mammary tumor tissue was fixed in 4% paraformaldehyde overnight and paraffin-embedded. Five micron sections were prepared and placed onto glass microscope slides. The sample was processed following the TumorTACS Kit protocol (Catalog # 4815-30-K). Brown stained nuclei indicate apoptotic cells.

Citations for TumorTACS In Situ Apoptosis Detection Kit

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

21 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. Renal and hepatic artery embolization with Pickering gel emulsion of lipiodol in rabbit
    Authors: H Zhang, Y Ren, H Li, C Zheng, K Qian
    BMC Cancer, 2022-12-12;22(1):1300.  2022-12-12
  2. Multi-Lens Arrays (MLA)-Assisted Photothermal Effects for Enhanced Fractional Cancer Treatment: Computational and Experimental Validations
    Authors: H Kim, H Pyo, H Kim, HW Kang
    Cancers, 2021-03-08;13(5):.  2021-03-08
  3. Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2?+?murine breast cancer model
    Authors: F Andreata, A Bonizzi, M Sevieri, M Truffi, M Monieri, L Sitia, F Silva, L Sorrentino, R Allevi, P Zerbi, B Marchini, E Longhi, R Ottria, S Casati, R Vanna, C Morasso, M Bellini, D Prosperi, F Corsi, S Mazzucchel
    Sci Rep, 2020-07-10;10(1):11425.  2020-07-10
  4. Inhibition of Heparanase Expression Results in Suppression of Invasion, Migration and Adhesion Abilities of Bladder Cancer Cells
    Authors: Y Tatsumi, M Miyake, K Shimada, T Fujii, S Hori, Y Morizawa, Y Nakai, S Anai, N Tanaka, N Konishi, K Fujimoto
    Int J Mol Sci, 2020-05-27;21(11):.  2020-05-27
  5. Tussilagone Reduces Tumorigenesis by Diminishing Inflammation in Experimental Colitis-Associated Colon Cancer
    Authors: SH Nam, JK Kim
    Biomedicines, 2020-04-11;8(4):.  2020-04-11
  6. Combined Treatment with MEK and mTOR Inhibitors is Effective in In Vitro and In Vivo Models of Hepatocellular Carcinoma
    Authors: X Liu, J Hu, X Song, K Utpatel, Y Zhang, P Wang, X Lu, J Zhang, M Xu, T Su, L Che, J Wang, M Evert, DF Calvisi, X Chen
    Cancers (Basel), 2019-07-03;11(7):.  2019-07-03
  7. SPARC correlates with unfavorable outcome and promotes tumor growth in lung squamous cell carcinoma
    Authors: J Xu, S Yang, X Gu, H Shen, L Wang, W Xu, L Fang, Y Mao, L Xu, Y Chen, W Fan, J Wang
    Exp. Mol. Pathol., 2019-06-21;0(0):104276.  2019-06-21
  8. IPMK Mediates Activation of ULK Signaling and Transcriptional Regulation of Autophagy Linked to Liver Inflammation and Regeneration
    Authors: P Guha, R Tyagi, S Chowdhury, L Reilly, C Fu, R Xu, AC Resnick, SH Snyder
    Cell Rep, 2019-03-05;26(10):2692-2703.e7.  2019-03-05
  9. Cyclopamine tartrate, a modulator of hedgehog signaling and mitochondrial respiration, effectively arrests lung tumor growth and progression
    Authors: SP Kalainayak, P Ghosh, S Dey, KE Fitzgerald, S Sohoni, PC Konduri, M Garrossian, L Liu, L Zhang
    Sci Rep, 2019-02-05;9(1):1405.  2019-02-05
  10. Non-obstructive vas deferens and epididymis loss in cystic fibrosis rats
    Authors: ZE Plyler, SE Birket, BD Schultz, JS Hong, SM Rowe, CF Petty, MR Crowley, DK Crossman, TR Schoeb, EJ Sorscher
    Mech. Dev., 2018-11-02;155(0):15-26.  2018-11-02
  11. Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma.
    Authors: Barone T, Burkhart C, Safina A, Haderski G, Gurova K, Purmal A, Gudkov A, Plunkett R
    Neuro Oncol, 2017-02-01;19(2):186-196.  2017-02-01
  12. Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphoma.
    Authors: Jain S, Stroopinsky D, Yin L, Rosenblatt J, Alam M, Bhargava P, Clark R, Kupper T, Palmer K, Coll M, Rajabi H, Pyzer A, Bar-Natan M, Luptakova K, Arnason J, Joyce R, Kufe D, Avigan D
    Blood, 2015-06-05;126(3):354-62.  2015-06-05
  13. Preclinical pharmacologic evaluation of pralatrexate and romidepsin confirms potent synergy of the combination in a murine model of human T-cell lymphoma.
    Authors: Jain S, Jirau-Serrano X, Zullo K, Scotto L, Palermo C, Sastra S, Olive K, Cremers S, Thomas T, Wei Y, Zhang Y, Bhagat G, Amengual J, Deng C, Karan C, Realubit R, Bates S, O'Connor O
    Clin Cancer Res, 2015-02-12;21(9):2096-106.  2015-02-12
  14. Nitidine chloride inhibits hepatic cancer growth via modulation of multiple signaling pathways.
    Authors: Lin, Jiumao, Shen, Aling, Chen, Hongwei, Liao, Jun, Xu, Teng, Liu, Liya, Lin, Jing, Peng, Jun
    BMC Cancer, 2014-09-30;14(0):729.  2014-09-30
  15. TNF-related apoptosis-inducing ligand enhances vinorelbine-induced apoptosis and antitumor activity in a preclinical model of non-small cell lung cancer.
    Authors: Zhu K, Fang W, Chen Y, Lin S, Chen X
    Oncol Rep, 2014-07-11;32(3):1234-42.  2014-07-11
  16. Bifurcation of axons from cranial sensory neurons is disabled in the absence of Npr2-induced cGMP signaling.
    Authors: Ter-Avetisyan G, Rathjen F, Schmidt H
    J Neurosci, 2014-01-15;34(3):737-47.  2014-01-15
  17. Molecular chaperone gp96 is a novel therapeutic target of multiple myeloma.
    Authors: Hua Y, White-Gilbertson S, Kellner J, Rachidi S, Usmani S, Chiosis G, Depinho R, Li Z, Liu B
    Clin Cancer Res, 2013-09-27;19(22):6242-51.  2013-09-27
  18. Distinct phospholipase C-beta isozymes mediate lysophosphatidic acid receptor 1 effects on intestinal epithelial homeostasis and wound closure.
    Authors: Lee S, Leoni G, Neumann P, Chun J, Nusrat A, Yun C
    Mol Cell Biol, 2013-03-11;33(10):2016-28.  2013-03-11
  19. Experimental mild renal insufficiency mediates early cardiac apoptosis, fibrosis, and diastolic dysfunction: a kidney-heart connection.
    Authors: Martin F, McKie P, Cataliotti A, Sangaralingham S, Korinek J, Huntley B, Oehler E, Harders G, Ichiki T, Mangiafico S, Nath K, Redfield M, Chen H, Burnett J
    Am J Physiol Regul Integr Comp Physiol, 2011-11-09;302(2):R292-9.  2011-11-09
  20. Rapamycin induces Bad phosphorylation in association with its resistance to human lung cancer cells.
    Authors: Liu Y, Sun S, Owonikoko T, Sica G, Curran W, Khuri F, Deng X
    Mol Cancer Ther, 2011-11-04;11(1):45-56.  2011-11-04
  21. Recombinant VP1, an Akt inhibitor, suppresses progression of hepatocellular carcinoma by inducing apoptosis and modulation of CCL2 production.
    Authors: Chen TA, Wang JL, Hung SW, Chu CL, Cheng YC, Liang SM
    PLoS ONE, 2011-08-03;6(8):e23317.  2011-08-03

FAQs

No product specific FAQs exist for this product, however you may

View all FAQs

Reviews for TumorTACS In Situ Apoptosis Detection Kit

There are currently no reviews for this product. Be the first to review TumorTACS In Situ Apoptosis Detection Kit and earn rewards!

Have you used TumorTACS In Situ Apoptosis Detection Kit?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review